findmyKOL
Clinical trialNCT00324727CompletedPhase 3Interventional

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

SponsorDelcath Systems Inc.Enrollment93Intraocular MelanomaMelanoma (Skin)Metastatic Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • John Wayne Cancer Institute at Saint John'S Health Center

    Santa Monica, California, United States

  • Swedish Medical Center

    Englewood, Colorado, United States

  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida

    Tampa, Florida, United States

  • Greenebaum Cancer Center at University of Maryland Medical Center

    Baltimore, Maryland, United States

  • Warren Grant Magnuson Clinical Center - Nci Clinical Trials Referral Office

    Bethesda, Maryland, United States

  • Carol G. Simon Cancer Center at Morristown Memorial Hospital

    Morristown, New Jersey, United States

  • Cancer Center of Albany Medical Center

    Albany, New York, United States

  • Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

    Columbus, Ohio, United States

  • Providence Cancer Center at Providence Portland Medical Center

    Portland, Oregon, United States

  • St. Luke'S Cancer Network at St. Luke'S Hospital

    Bethlehem, Pennsylvania, United States

  • Upmc Cancer Centers

    Pittsburgh, Pennsylvania, United States

  • University of Texas Medical Branch

    Galveston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2006
Primary completion
31 Aug 2012
Completion
31 Aug 2012
Last update posted
21 Jun 2021
Registered enrollment
93
Registry id
NCT00324727

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.